Mona Chetan Patel - Sep 9, 2024 Form 4 Insider Report for Envoy Medical, Inc. (COCH)

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Mona Chetan Patel pursuant to Power of Attorney previously filed.
Stock symbol: COCH
Transactions as of: Sep 9, 2024
Transactions value $: $16,520
Form type: 4
Date filed: 9/11/2024, 04:50 PM
Previous filing: Oct 17, 2023
Next filing: Nov 22, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COCH	Class A Common Stock	Purchase	$3.2K	+1K		$3.20	1K	Sep 9, 2024	Direct
transaction	COCH	Class A Common Stock	Purchase	$13.3K	+4K	+400%	$3.33	5K	Sep 11, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	COCH	Stock Option (right to buy)						25K	Sep 9, 2024	Class A Common Stock	25K	$2.40	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a weighted average price. These shares of Class A Common Stock were purchased in multiple transactions at prices ranging from $3.28 to $3.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
F2	Options to purchase 6,250 shares vest on 10/15/2024, and the remaining 18,750 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.

Content

Represents a weighted average price. These shares of Class A Common Stock were purchased in multiple transactions at prices ranging from $3.28 to $3.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Options to purchase 6,250 shares vest on 10/15/2024, and the remaining 18,750 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.